Harnessing the potential of mesenchymal stem cells for IVD regeneration

Current Stem Cell Research and Therapy

Volumn 10, Issue 4, 2015, Pages 296-306

  Clarke, Louise E ^a   Richardson, Stephen M ^a   Hoyland, Judith A ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Biomaterials; Differentiation; Intervertebral disc; Lower back pain; Mesenchymal stem cells; Microenvironment; Tissue engineering

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL POPULATION; CELLS BY BODY ANATOMY; GENE EXPRESSION; HUMAN; INTERVERTEBRAL DISK DEGENERATION; LOW BACK PAIN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROENVIRONMENT; PRIORITY JOURNAL; STEM CELL; STEM CELL NICHE; TISSUE ENGINEERING; TISSUE SCAFFOLD; WEIGHT REDUCTION; ANIMAL; BIOLOGICAL THERAPY; CYTOLOGY; INTERVERTEBRAL DISC DEGENERATION; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; REGENERATION;

ANIMALS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; HUMANS; INTERVERTEBRAL DISC DEGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; REGENERATION;

EID: 84930515622     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X10666141202112638     Document Type: Article

References (139)

1. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003; 290(18): 2443-54.
2. Walker BF. The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. J Spinal Disord 2000; 13(3): 205-17.
3. Hoy D, Bain C, Williams G, et al.A systematic review of the global prevalence of low back pain. Arthritis Rheum 2012; 64(6): 2028-37.
4. Junpier M, Le TK, Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opin Pharmacother 2009; 10(16): 2581-92.
5. Papageorgiou AC, Croft PR, Ferry S, Jayson MI, Silman AJ. Estimating the prevalence of low back pain in the general population. Evidence from the South Manchester Back Pain Survey. Spine (Phila Pa 1976). 1995; 20(17): 1889-94.
6. Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain 2000; 84(1): 95-103.
7. The costs of accidents at work, HS(G)96 2nd Edition, HMSO 1997.
8. Cheung KM, Karppinen J, Chan D, et al.Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine (Phila Pa 1976) 2009; 34(9): 934-40.
9. Samartzis D, Karppinen J, Mok F, Fong DY, Luk KD, Cheung KM. A population-based study of juvenile disc degeneration and its association with overweight and obesity, low back pain, and diminished functional status. J Bone Joint Surg Am 2011; 93(7): 662-70.
10. Takatalo J, Karppinen J, Niinimaki J, et al.Does lumbar disc degeneration on magnetic resonance imaging associate with low back symptom severity in young Finnish adults? Spine (Phila Pa 1976) 2011; 36(25): 2180-9.
11. Trout JJ, Buckwalter JA, Moore KC. Ultrastructure of the human intervertebral disc: II. Cells of the nucleus pulposus. Anat Rec 1982; 204(4): 307-14
12. Urban JP, McMullin JF. Swelling pressure of the inervertebral disc: influence of proteoglycan and collagen contents. Biorheology 1985; 22(2): 145-57.
13. Roughley P. Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine (Phila Pa 1976) 2004; 29: 2691-9.
14. Moon SM, Yoder, JH, Wright AC, Smith LJ, Vresilovic, EJ, Elliott DM. Evaluation of intervertebral disc cartilaginous endplate structure using magnetic resonance imaging. Eur Spine J 2013; 22 (8): 1820-8.
15. Adams, MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976) 2006; 3 1: 2151-61.
16. Holm S, Nachemson A. Nutrition of the intervertebral disc: acute effects of cigarette smoking. An experimental animal study. Ups J Med Sci 1988; 93: 91-99.
17. Hirano N, Tsuji H, Ohshima H, Kitano S, Itoh T, Sano A. Analysis of rabbit intervertebral disc physiology based on water metabolism. II. Changes in normal intervertebral discs under axial vibratory load. Spine (Phila Pa 1976) 1988; 13: 1297-302.
18. Deyo RA, Bass JE. Lifestyle and low-back pain.The influence of smoking and obesity. Spine (Phila Pa 1976) 1989; 14: 501-6.
19. Wilder DG, Pope MH, Magnusson M. Mechanical stress reduction during seated jolt/vibration exposure. Semin Perinatol 1996; 20: 54-60.
20. Adams MA, Freeman BJ, Morrison HP, Nelson IW, Dolan P. Mechanical initiation of intervertebral disc degeneration. Spine (Phila Pa 1976) 2000; 25: 1625-36.
21. Urban JP, Smith S, Fairbank JC. Nutrition of the intervertebral disc. Spine (Phila Pa 1976) 2004; 29: 2700-9.
22. Bibby SR, Urban JP. Effect of nutrient deprivation on the viability of intervertebral disc cells. Eur Spine J 2004; 13: 695-701.
23. Stokes, IA, Iatridis, JC. Mechanical Conditions that Accelerate Intervertebral Disc Degeneration: Overload Versus Immobilization. Spine (Phila Pa 1976) 2004; 29: 2724-32.
24. Freemont AJ, Watkins A, Le MC, Baird P, Jeziorska M, Knight MT, Ross ER, O’Brien JP, Hoyland JA. Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol 2002; 197: 286-92.
25. Boos N, Nerlich AG, Wiest I, von der Mark K, Aebi M. Immunolocalization of type X collagen in human lumbar intervertebral discs during ageing and degeneration. Histochem Cell Biol 1997; 108: 471-80.
26. Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt KF, Nerlich AG. Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine (Phila Pa 1976) 2002; 27: 2631-44.
27. Zhao CQ, Wang LM, Jiang LS, Dai LY The cell biology of intervertebral disc aging and degeneration. Ageing Res Rev 2007; 6: 247-61.
28. Johnson WE, Eisenstein SM, Roberts S . Cell cluster formation in degenerate lumbar intervertebral discs is associated with increased disc cell proliferation. Connect Tissue Res 2001; 42: 197-207.
29. Gruber HE, Hanley EN Jr. Analysis of aging and degeneration of the human intervertebral disc. Comparison of surgical specimens with normal controls. Spine (Phila Pa 1976) 1998; 23: 751-7.
30. Buckwalter JA. Aging and degeneration of the human intervertebral disc. Spine (Phila Pa 1976) 1995; 20, 1307-14.
31. Costi JJ, Stokes IA, Gardner-Morse MG, Iatridis JC. Frequencydependent behavior of the intervertebral disc in response to each of six degree of freedom dynamic loading: solid phase and fluid phase contributions. Spine (Phila Pa 1976) 2008; 33: 1731-8.
32. O’Connell GD, Guerin HL, Elliott DM. Theoretical and experimental evaluation of human annulus fibrosus degeneration. J. Biomech. Eng 2007; 131: 111007.
33. Alini M, Roughley PJ, Antoniou J, Stoll T, Aebi M. A biological approach to treating disc degeneration: not for today, but maybe for tomorrow. Eur Spine J 2002; 11(Suppl 2): S215-S220.
34. Roberts S, Caterson B, Menage J, Evans E H, Jaffray DC, Eisenstein SM. Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine(Phila Pa 1976) 2000; 25: 3005-3013.
35. Bachmeier BE, Nerlich A, Mittermaier N, et al.Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration. Eur. Spine J 2009; 18: 1573-86.
36. Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol 2004; 204: 47-54.
37. Pockert AJ, Richardson SM, Le Maitre CL, et al.Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. Arthritis Rheum 2009; 60: 482-91.
38. Richardson SM, Doyle P, Minogue BM, Gnanalingham K, Hoyland JA. Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc. Arthritis Res Ther 2009; 11: R126.
39. Le Maitre CL, Pockert A, Buttle DJ, Freemont AJ, Hoyland JA. Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans 2007; 35(4): 652-5.
40. Podichetty VK. The aging spine: the role of inflammatory mediators in intervertebral disc degeneration. Cell Mol Biol (Noisy-legrand). 2007; 53(5): 4-18.
41. Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 2005 7: R732-45.
42. Le Maitre CL, Freemont AJ, Hoyland JA. A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration. Int J Exp Pathol 2006; 87: 17-28.
43. Le Maitre CL, Hoyland JA, Freemont AJ. Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Res Ther 2007; 9: R77
44. Le Maitre CL, Hoyland JA, Freemont AJ. Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study. Arthritis Res Ther 2007; 9: R83.
45. Hoyland, JA, Le Maitre, CL, Freemont, AJ. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxford) 2008; 47 (6): 809-14.
46. Lee JM, Song JY, Baek M, Jung HY, Kang H, Han IB, Kwon YD, Shin DE. Interleukin-1beta induces angiogenesis and innervation in human intervertebral disc degeneration. J Orthop Res 2011; 29: 265-9
47. Bachmeier BE, Nerlich AG, Weiler C, Paesold G, Jochum M, Boos N. Analysis of tissue distribution of TNF-alpha, TNFalphareceptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. Ann N Y Acad Sci 2007; 1096: 44-54
48. Weiler C, Nerlich AG, Bachmeier BE, Boos N. Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine (Phila Pa 1976) 2005; 30: 44-53
49. Roberts S, Evans EH, Kletsas D, Jaffray DC, Eisenstein SM. Senescence in human intervertebral discs. Eur Spine J 2006; 15 (Suppl 3): S312-6.
50. Le Maitre CL, Freemont AJ, Hoyland JA. Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther 2007; 9: R45.
51. Gruber HE, Ingram JA, Norton HJ, Hanley EN JR. Senescence in cells of the aging and degenerating intervertebral disc: immunolocalization of senescence-associated beta-galactosidase in human and sand rat discs. Spine (Phila Pa 1976) 2007; 32: 321-7.
52. Chou R, Huffman LH. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007; 147: 492-504.
53. Slade SC, Keating JL. Unloaded movement facilitation exercise compared to no exercise or alternative therapy on outcomes for people with nonspecific chronic low back pain: a systematic review. J Manipulative Physiol Ther 2007; 30: 301-11.
54. Zhang Y, An SH, Tannoury C Thonar EJ, Freedman MK, Anderson DG. Biological treatment for degenerative disc disease: implications for the field of physical medicine and rehabilitation. Am J Phys Med Rehabil 2008; 87: 694-702.
55. Lee CK. Accelerated degeneration of the segment adjacent to a lumbar fusion. Spine (Phila Pa 1976) 1988; 13: 375-7.
56. Gillet P. The fate of the adjacent motion segments after lumbar fusion. J Spinal Disord Tech 2003; 16: 338-45.
57. Berg S, Tropp HT, Leivseth G. Disc height and motion patterns in the lumbar spine in patients operated with total disc replacement or fusion for discogenic back pain. Results from a randomized controlled trial. Spine J 2011; 11: 991-8.
58. Gruber HE, Fisher EC JR, Desai B, Stasky AA, Hoelscher G, Hanley EN JR. Human intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and responsiveness to TGF-beta1. Exp Cell Res 1997; 235: 13-21.
59. Masuda K, Takegami K, An H, et al. Recombinant osteogenic protein-1 upregulates extracellular matrix metabolism by rabbit annulus fibrosus and nucleus pulposus cells cultured in alginate beads. J Orthop Res 2003; 21: 922-30.
60. Tim Yoon S, Su Kim K, Li J, Soo Park J, Akamaru T, Elmer WA, Hutton WC. The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine (Phila Pa 1976)2003; 28 : 1773-80.
61. Li X, Leo BM, Beck G, Balian G, Anderson GD. Collagen and proteoglycan abnormalities in the GDF-5-deficient mice and molecular changes when treating disk cells with recombinant growth factor. Spine (Phila Pa 1976) 2004; 29: 2229-34.
62. Osada R, Oshima, H, Ishihara H, Yudoh K, Sakai K, Matsui H, Tsuji H. Autocrine/paracrine mechanism of insulin-like growth factor-1 secretion, and the effect of insulin-like growth factor-1 on proteoglycan synthesis in bovine intervertebral discs. J Orthop Res 1996; 14: 690-9.
63. Imai Y, Okuma M, An HS, Nakagawa K, Yamada M, Muehleman C, Thonar E, Masuda K. Restoration of disc height loss by recombinant human osteogenic protein-1 injection into intervertebral discs undergoing degeneration induced by an intradiscal injection of chondroitinase ABC. Spine (Phila Pa 1976) 2007; 32: 1197-205.
64. Wei A, Williams LA, Bhargav D, Shen B, Kishen T, Duffy N, Diwan AD. BMP13 prevents the effects of annular injury in an ovine model. Int J Biol Sci 2009; 5: 388-96.
65. Gruber HE, Johnson TL, Leslie K, et al.Autologous intervertebral disc cell implantation: a model using Psammomys obesus, the sand rat. Spine (Phila Pa 1976) 2002; 27: 1626-33.
66. Hohaus C, Ganey TM, Minkus Y, Meisel HJ. Cell transplantation in lumbar spine disc degeneration disease. Eur Spine J 2008; 17 (Suppl 4): 492-503.
67. Meisel HJ, Siodla V, Ganey T, Minkus Y, Hutton WC, Alasevic OJ. Clinical experience in cell-based therapeutics: disc chondrocyte transplantation A treatment for degenerated or damaged intervertebral disc. Biomol Eng 2007; 24(1): 5-21.
68. Risbud MV, Guttapalli A, Tsai TT, et al.Evidence for skeletal progenitor cells in the degenerate human intervertebral disc. Spine (Phila Pa 1976) 2007; 32(23): 2537-44.
69. Henriksson H, Thornemo M, Karlsson C, et al.Identification of cell proliferation zones, progenitor cells and a potential stem cell niche in the intervertebral disc region: a study in four species. Spine (Phila Pa 1976) 2009; 34(21): 2278-87.
70. Brisby H, Papadimitriou N, Brantsing C, Bergh P, Lindahl A, Barreto Henriksson H. The presence of local mesenchymal progenitor cells in human degenerated intervertebral discs and possibilities to influence these in vitro: a descriptive study in humans. Stem Cells Dev 2013; 22(5): 804-14.
71. Sakai D, Nakamura Y, Nakai T, et al.Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc. Nat Commun 2012; 3: 1264
72. Pittenger MF, Mackay AM, Beck SC, et al.Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
73. Risbud MV, Albert TJ, Guttapalli A, Vresilovic EJ, Hillibrand AS, Vaccaro AR, Shapiro IM. Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy. Spine (Phila Pa 1976) 2004; 29: 2627-32.
74. Richardson SM, Walker RV, Parker S, et al.Intervertebral disc cell-mediated mesenchymal stem cell differentiation. Stem Cells 2006; 24: 707-16.
75. Minogue BM, Richardson SM, Zeef LA, Freemont AJ, Hoyland JA. Characterization of the human nucleus pulposus cell phenotype and evaluation of novel marker gene expression to define adult stem cell differentiation. Arthritis Rheum 2010; 62(12): 3695-705.
76. Clarke LE, McConnell, JC, Sherratt, MJ, Derby, B, Richardson, SM, Hoyland, J.A. Growth differentiation factor 6 and transforming growth factor-beta differentially mediate mesenchymal stem cell differentiation, composition, and micromechanical properties of nucleus pulposus constructs. Arth Res Ther 2014; 16: R67
77. Le Maitre CL, Baird P, Freemont AJ, Hoyland JA. An in vitro study investigating the survival and phenotype of mesenchymal stem cells following injection into nucleus pulposus tissue. Arthritis Res Ther 2009; 11: R20.
78. Sakai D, Mochida J, Iwashina T, et al. Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine (Phila Pa 1976) 2005, 30, 2379-87.
79. Feng G, Zhao X, Liu H, et al.Transplantation of mesenchymal stem cells and nucleus pulposus cells in a degenerative disc model in rabbits: a comparison of 2 cell types as potential candidates for disc regeneration. J Neurosurg Spine 2011; 14: 322-9.
80. Hiyama A, Mochida J, Iwashina T, et al.Transplantation of mesenchymal stem cells in a canine disc degeneration model. J Orthop Res 2008; 26: 589-600.
81. Jeong JH, Jin ES, Min JK, et al.Human mesenchymal stem cells implantation into the degenerated coccygeal disc of the rat. Cytotechnology 2009; 59: 55-64.
82. Orozco L, Soler R, Morera C, Alberca M, Sanchez A, GarciaSancho J. Intervertebral disc repair by autologous mesenchymalbone marrow cells: a pilot study. Transplantation 2011; 92(7): 822-8.
83. Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA, Freemont AJ. Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol 2002; 55(2): 91-7.
84. Mwale F, Roughley P, Antoniou J. Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc. Eur Cell Mater. 2004; 8: 58-63. discussion-4.
85. Sakai D, Nakai T, Mochida J, Alini M, Grad S. Differential phenotype of intervertebral disc cells microarray and immunohistochemical analysis of canine nucleus pulposus and anulus fibrosus. Spine (Phila Pa 1976) 2009; 34(14): 1448-56.
86. Lee CR, Sakai D, Nakai T, et al.A phenotypic comparison of intervertebral disc and articular cartilage cells in the rat. Eur Spine J 2007; 16(12): 2174-85.
87. Minogue BM, Richardson SM, Zeef LA, Freemont AJ, Hoyland JA. Transcriptional profiling of bovine intervertebral disc cells: implications for identification of normal and degenerate human intervertebral disc cell phenotypes. Arthritis Res Ther 2010; 12(1): R22.
88. Power KA, Grad S, Rutges JP, et al.Identification of cell surfacespecific markers to target human nucleus pulposus cells: expression of carbonic anhydrase XII varies with age and degeneration. Arthritis Rheum 2011; 63(12): 3876-86.
89. Gantenbein-Ritter B, Benneker LM, Alini M, Grad S. Differential response of human bone marrow stromal cells to either TGF-β (1) or rhGDF-5. Eur Spine J 2011; 20: 962-971.
90. Stoyanov JV, Gantenbein-Ritter B, Bertolo A, Aebli N, Baur M, Alini M, Grad S. Role of hypoxia and growth differentiation factor-5 on differentiation of human mesenchymal stem cells toward intervertebral nucleus pulposus like cells. Eur Cell Mater 2011; 21: 533-47.
91. Peroglio M, Eglin D, Benneker LM, Alini M, Grad S. Thermoreversible hyaluronan-based hydrogel supports in vitro and ex vivo disc-like differentiation of human mesenchymal stem cells. Spine J 2013; 13: 1627-39.
92. Buckley CT, Kelly DJ. Expansion in the presence of FGF-2 enhances the functional development of cartilaginous tissues engineered using infrapatellar fat pad derived MSCs. J Mech Behav Biomed Mater 2012; 11: 102-11.
93. Yu DA, Han J, Kim BS. Stimulation of chondrogenic differentiation of mesenchymal stem cells. Int J Stem Cells 2012; 5: 16-22.
94. Longobardi L, O'Rear L, Aakula S, et al.Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res. 2006; 21(4): 626-36.
95. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002; 2: 389-406.
96. Settle SH Jr, Rountree RB, Sinha A, Thacker A, Higgins K, Kingsley DM. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev Biol 2003; 254: 116-30.
97. Asai-Coakwell M, French CR, Ye M, et al.Incomplete penetrance and phenotypic variability characterize Gdf6-attributable oculoskeletal phenotypes. Hum Mol Genet 2009; 18: 1110-21.
98. Le Maitre CL, Freemont AJ, Hoyland JA. Expression of cartilagederived morphogenetic protein in human intervertebral discs and its effect on matrix synthesis in degenerate human nucleus pulposus cells. Arthritis Res Ther 2009; 11: R137.
99. Oldershaw RA, Baxter MA, Lowe ET, et al.Directed differentiation of human embryonic stem cells toward chondrocytes. Nat Biotechnol 2010; 28: 1187-94.
100. Ozasa Y, Gingery A, Thoreson AR, An KN, Zhao C, Amadio PC. A comparative study of the effects of growth differentiation factor 5 on muscle-derived stem cells and bone marrow stromal cells in an in vitro tendon healing model. J Hand Surg Am 2014; 39: 1706-13.
101. Tassabehji M, Fang ZM, Hilton EN, et al.Mutations in GDF6 are associated with vertebral segmentation defects in Klippel-Feil syndrome. Hum Mutat 2008; 29: 1017-27
102. Lu ZF, Zandieh Doulabi B, Wuisman PI, Bank RA, Helder MN. Differentiation of adipose stem cells by nucleus pulposus cells: configuration effect. Biochem Biophys Res Commun 2007; 359: 991-6.
103. Tapp H, Deepe R, Ingram JA, Kuremsky M, Hanley EN Jr, Gruber HE. Adipose-derived mesenchymal stem cells from the sand rat: transforming growth factor beta and 3D co-culture with huam disc cells stimulate proteoglycan and collagen type I rich extracellulr matrix. Arthritis Res Ther 2008; 10: R89.
104. Jin ES, Min J, Jeon SR, Choi KH, Jeong JH. Analysis of molecular expression in adipose tissue-derived mesenchymal stem cells: prospects for use in the treatment of intervertebral disc degeneration. J Korean Neurosurg Soc 2013; 53: 207-12.
105. Jeong JH, Lee JH, Jin ES, Min JK, Jeon SR, Choi KH. Regeneration of intervertebral discs in a rat disc degeneration model by implanted adipose-tissue-derived stromal cells. Acta Neurochir (Wien) 2010; 152: 1771-77.
106. Marfia G, Campanella R, Navone S, et al.Potential use of human adipose mesenchymal stromal cells for intervertebral disc regeneration: a preliminary study on biglycan-deficient murine model of chronic disc degeneration. Arthritis Res Ther 2014; 16: 457.
107. Ratner BD, Bryant SJ. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng 2004; 6: 41-75.
108. Silva-Correia J, Oliveria JM, Caridade SG, Oliveria JT, Sousa RA, Mano JF, Reis RL. Gellan gum-based hydrogels for intervertebral disc tissue-engineering applications. J Tissue Eng Regen Med 2011; 5: e97-107.
109. See EY, Toh SL, Goh JC. Effects of radial compression on a novel simulated intervertebral disc-like assembly using bone marrowderived mesenchymal stem cell cell-sheets for annulus fibrosus regeneration. Spine (Phila Pa 1976) 2011; 36: 1744-51.
110. Guillaume O, Daly A, Lennon K, Gansau J, Buckley SF, Buckley CT. Shape-memory porous alginate scaffolds for regeneration of the annulus fibrosus: effect of TGF-b3 supplementation and oxygen culture conditions. Acta Biomater 2014; 10: 1985-95.
111. Nesti LJ, Li WJ, Shanti RM, Jiang YJ, Jackson W, Freedman BA, Kuklo TR, Giuliani JR, Tuan RS. Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam. Tissue Eng Part A 2008; 14: 1527-37.
112. Lazebnik M, Singh M, Glatt P, Friis LA, Berkland CJ, Detamore MS. Biomimetic method for combining the nucleus pulposus and annulus fibrosus for intervertebral disc tissue engineering. J Tissue Eng Regen Med 2011; 5: e179-87.
113. Richardson SM, Hughes N, Hunt JA, Freemont AJ, Hoyland JA. Human mesenchymal stem cell differentiation to NP-like cells in chitosan-glycerophosphate hydrogels. Biomaterials 2008; 29: 85-93.
114. Truong VX, Ablett MP, Gilbert HTJ, et al.In situ-forming robust chitosan-poly(ethylene glycol) hydrogels prepared by copper-free azide-alkyne click reaction for tissue engineering. Biomaterials Science 2014; 2: 167-175.
115. Crevensten G, Walsh AJ, Anathakrishnan D, Page P, Wahba GM, Lotz JC, Berven S. Intervertebral disc cell therapy for regeneration: mesenchymal stem cell implantation in rat intervertebral discs. Ann Biomed Eng 2004; 32: 430-4.
116. Calderon L, Collin E, Velasco-Bayon D, Murphy M, O’Halloran D, Pandit A. Type II collagen-hyaluronan hydrogel--a step towards a scaffold for intervertebral disc tissue engineering. Eur Cell Mater 2010; 20: 134-48.
117. Bertolo A, Mehr M, Aebli N, Baur M, Ferguson SJ. Influence of different commercial scaffolds on the in vitro differentiation of human mesenchymal stem cells to nucleus pulposus-like cells. Eur Spine J 2012; 21: S826-S838.
118. Naqvi SM, Buckley CT. Differential response of encapsulated nucleus pulposus and bone marrow stem cells in isolation and coculture in isolation and coculture in alginate and chitosan hydrogels. Tissue Eng 2014; DOI: 10.1089/ten.tea.2013.0719
119. Fontana G, Thomas D, Collin E, Pandit A. Microgel microenvironment primes adipose-derived stem cells towards an NP cells-like phenotype. Adv Healthcare Mater 2014; DOI: 10.1089/ten.tea.2013.0719
120. Li YY, Diao HJ, Chik TK, Chow CT, An XM, Leung V, Cheung KMC, Chan BP. Delivering mesenchymal stem cells in collagen microsphere carriers to a rabbit degenerative disc: reduced risk of osteophyte formation. Tissue Eng Part A 2014; 20: 1379-91.
121. Gupta MS, Cooper ES, Nicoll SB. Transfroming growth factor-beta 3 stimulates cartilage matrix elaboration by human marrow-derived stromal cells encapsulated in photocrosslinked carboxymethylcellulose hydrogels: potential for nucleus pulposus replacement. Tissue Eng Part A 2011; 17: 2903-10.
122. Smith LJ, Gorth DJ, Showalter BL, et al. In vitro characterization of stem-cell-seeded triple-interpenetrating-netweok hydrogel for functional regeneration of the nucleus pulposus. Tissue Eng Part A 2014; 20: 1841-9.
123. Pereira CL, Goncalves RM, Peroglio M, et al.The effect of hyaluronan-based delivery of stromal cell-derived factor-1 on the recruitment of MSCs in degenerating intervertebral discs. Biomaterials 2014; 35: 8144-53.
124. Bibby SR, Jones DA, Ripley RM, Urban JP. Metabolism of the intervertebral disc: effects of low levels of oxygen, glucose, and pH on rates of energy metabolism of bovine nucleus pulposus cells. Spine (Phila Pa 1976) 2005; 30: 487-96.
125. Ishihara H, Urban JP. Effects of low oxygen concentrations and metabolic inhibitors on proteoglycan and protein synthesis rates in the intervertebral disc. J Orthop Res 1999; 17: 829-35.
126. Soukane DM, Shirazi-Adl A, Urban JP. Computation of coupled diffusion of oxygen, glucose and lactic acid in an intervertebral disc. J Biomech 2007; 40: 2645-54.
127. Horner HA, Urban JP. Volvo Award Winner in Basic Science Studies: Effect of nutrient supply on the viability of cells from the nucleus pulposus of the intervertebral disc. Spine (Phila Pa 1976) 2001; 26: 2543-9.
128. Razaq S, Wilkins RJ, Urban JP. The effect of extracellular pH on matrix turnover by cells of the bovine nucleus pulposus. Eur Spine J 2003; 12: 341-9.
129. Grunhagen T, Wilde G, Soukane DM, Shirazi-Adl SA, Urban JP. Nutrient supply and intervertebral disc metabolism. J Bone Joint Surg Am 2006; 88 (Suppl 2): 30-5.
130. Matsumoto, T., M. Kawakami, K. Kuribayashi, T. Takenaka, and T. Tamaki. Cyclic mechanical stretch increases the growth rate and collagen synthesis of nucleus cells in vitro. Spine 1999; 24: 315-9.
131. MacLean JJ, Lee CR, Alini M, Iatridis JC. Anabolic and Catabolic mRNA Levels of the Intervertebral Disc Vary with the Magnitude and Frequency of In vivo dynamic Compression. J Orth Res 2004; 22: 1193-200.
132. Walsh AJ, Lotz JC. Biological Response of the Intervertebral Disc to Dynamic Loading. J Biomech 2004; 37: 329-37.
133. Walter BA, Korecki CL, Purmessur D, Roughley PJ, Michalek, AJ, Iatridis JC. Complex Loading Affects Intervertebral Disc Mechanics and Biology. Osteoarthritis Cartilage 2011; 19: 1011-8.
134. Wuertz K, Godburn K, Neidlinger-Wilke C, Urban J, Iatridis JC. Behavior of mesenchymal stem cells in the chemical microenvironment of the intervertebral disc. Spine (Phil Pa 1976)2008; 33: 1843-49.
135. Liang C, Li H, Tao Y, et al.Responses of human adipose-derived mesenchymal stem cells to chemical microenvironment of the intervertebral disc. J Transl Med 2012; 10: 49. doi:10.1186/1479-5876-10-49
136. Wuertz K, Godburn K, Iatridis JC. MSC response to pH levels found in degenerating intervertebral discs. Biochem Biophys Res Commun 2009; 379: 824-9.
137. Felka T, Schafer R, Schewe B, Benz K, Aicher WK. Hypoxia reduces the inhibitory effect of IL-1beta on chondrogenic differentiation of FCS-free expanded MSC. Osteoarthritis Cartilage 2009; 10: 1368-76.
138. Markway BD, Tan GK, Hudson JE, Cooper-White JJ, Doran MR. Enhanced chondrogenic differentiation of human bone marrowderived mesenchymal stem cells in low oxygen environment micropellet cultures. Cell Transplant 2010; 19: 29-42.
139. Li H, Tao Y, Liang C, Han B, Li F, Chen G, Chen Q. Influence of hypoxia in the intervertebral disc on the biological behaviors of rat adipose-and nucleus pulposus-derived mesenchymal stem cells. Cells Tissues Organs 2013; 198: 266-77.